{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:28:04Z","timestamp":1768800484838,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gallbladder cancer (GBC) is a malignant cancer with very poor prognosis. Although promyelocytic leukemia zinc-finger protein (PLZF) was reported to be deregulated in numerous cancers and also relevant to clinical prognosis, its role in GBC progression has been little known. In this study, we found PLZF expression was decreased in GBC, correlating to advanced TNM stage, distant metastasis, and shorter overall survival. Moreover, ectopic PLZF expression in GBC cells (NOZ and GBC-SD) significantly reduced the cell proliferation, migration, and invasion. Consistently, overexpression of PLZF in xenograft mice model could suppress tumor growth and liver metastasis. Mechanical investigations verified PLZF could regulate the expression of cell cycle arrest-associated gene p21 and epithelial\u2013mesenchymal transition (EMT)-related genes (E-cadherin and N-cadherin) in GBC cell lines. Importantly, PLZF remarkably increased the mRNA transcription of interferon-induced protein with tetratricopeptide repeat 2 (IFIT2) by increasing STAT1 protein level, a known factor involved in tumor progression. Furthermore, ablation of IFIT2 in PLZF overexpression cells abrogated the tumor-suppressive function of PLZF, at least partially, leading to impaired tumor growth and EMT program. These studies indicated PLZF inhibited the proliferation and metastasis via regulation of IFIT2. In conclusion, our study demonstrated PLZF could be a promising tumor biomarker for GBC, and also be a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-017-0107-3","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T12:30:03Z","timestamp":1516624203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2"],"prefix":"10.1038","volume":"9","author":[{"given":"Hui","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunwang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xince","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"107_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA. Cancer. J. Clin. 60, 277\u2013300 (2010).","journal-title":"CA. Cancer. J. Clin."},{"key":"107_CR2","doi-asserted-by":"publisher","first-page":"967472","DOI":"10.1155\/2015\/967472","volume":"2015","author":"R Kanthan","year":"2015","unstructured":"Kanthan, R., Senger, J. L., Ahmed, S. & Kanthan, S. C. Gallbladder cancer in the 21st century. J. Oncol. 2015, 967472 (2015).","journal-title":"J. Oncol."},{"key":"107_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00000658-199611000-00008","volume":"224","author":"DL Bartlett","year":"1996","unstructured":"Bartlett, D. L., Fong, Y., Fortner, J. G., Brennan, M. F. & Blumgart, L. H. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann. Surg. 224, 639\u2013646 (1996).","journal-title":"Ann. Surg."},{"key":"107_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00464-001-9085-7","volume":"16","author":"C Wullstein","year":"2002","unstructured":"Wullstein, C., Woeste, G., Barkhausen, S., Gross, E. & Hopt, U. T. Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg. Endosc. 16, 828\u2013832 (2002).","journal-title":"Surg. Endosc."},{"key":"107_CR5","doi-asserted-by":"publisher","first-page":"e24176","DOI":"10.1371\/journal.pone.0024176","volume":"6","author":"S Spicuglia","year":"2011","unstructured":"Spicuglia, S. et al. Characterisation of genome-wide PLZF\/RARA target genes. PLoS ONE 6, e24176 (2011).","journal-title":"PLoS ONE"},{"key":"107_CR6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V85.4.1083.bloodjournal8541083","volume":"85","author":"JD Licht","year":"1995","unstructured":"Licht, J. D. et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85, 1083\u20131094 (1995).","journal-title":"Blood"},{"key":"107_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/stem.2270","volume":"34","author":"TM Liu","year":"2016","unstructured":"Liu, T. M., Lee, E. H., Lim, B. & Shyh-Chang, N. Concise review: balancing stem cell self-renewal and differentiation with PLZF. Stem Cells (Dayton, Ohio) 34, 277\u2013287 (2016).","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"107_CR8","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1128\/MCB.23.24.9375-9388.2003","volume":"23","author":"MJ McConnell","year":"2003","unstructured":"McConnell, M. J. et al. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol. Cell. Biol. 23, 9375\u20139388 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"107_CR9","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/sj.onc.1207597","volume":"23","author":"F Felicetti","year":"2004","unstructured":"Felicetti, F. et al. Role of PLZF in melanoma progression. Oncogene 23, 4567\u20134576 (2004).","journal-title":"Oncogene"},{"key":"107_CR10","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/onc.2009.455","volume":"29","author":"M Cheung","year":"2010","unstructured":"Cheung, M. et al. The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene 29, 1633\u20131640 (2010).","journal-title":"Oncogene"},{"key":"107_CR11","doi-asserted-by":"publisher","first-page":"E2572","DOI":"10.1073\/pnas.1304318110","volume":"110","author":"Y Jin","year":"2013","unstructured":"Jin, Y. et al. Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer. Proc. Natl. Acad. Sci. USA 110, E2572\u2013E2581 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"107_CR12","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1096\/fj.13-229070","volume":"27","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers. FASEB J. 27, 4194\u20134203 (2013).","journal-title":"FASEB J."},{"key":"107_CR13","doi-asserted-by":"publisher","first-page":"e77922","DOI":"10.1371\/journal.pone.0077922","volume":"8","author":"J Cao","year":"2013","unstructured":"Cao, J. et al. PLZF mediates the PTEN\/AKT\/FOXO3a signaling in suppression of prostate tumorigenesis. PLoS ONE 8, e77922 (2013).","journal-title":"PLoS ONE"},{"key":"107_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.humpath.2015.06.021","volume":"46","author":"GQ Xiao","year":"2015","unstructured":"Xiao, G. Q. et al. Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma. Hum. Pathol. 46, 1607\u20131615 (2015).","journal-title":"Hum. Pathol."},{"key":"107_CR15","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1074\/jbc.M113.538751","volume":"289","author":"WI Choi","year":"2014","unstructured":"Choi, W. I. et al. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF\/CDKN1A) gene repression. J. Biol. Chem. 289, 18625\u201318640 (2014).","journal-title":"J. Biol. Chem."},{"key":"107_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-14-52","volume":"14","author":"K Matsuzawa","year":"2014","unstructured":"Matsuzawa, K. et al. Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms. BMC Endocr. Disord. 14, 52 (2014).","journal-title":"BMC Endocr. Disord."},{"key":"107_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1089\/jir.2012.0159","volume":"33","author":"NC Reich","year":"2013","unstructured":"Reich, N. C. A death-promoting role for ISG54\/IFIT2. J. Interferon Cytokine Res. 33, 199\u2013205 (2013).","journal-title":"J. Interferon Cytokine Res."},{"key":"107_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2009.04.013","volume":"30","author":"D Xu","year":"2009","unstructured":"Xu, D. et al. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity 30, 802\u2013816 (2009).","journal-title":"Immunity"},{"key":"107_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148\u2013154 (1989).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"107_CR20","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1182\/blood-2009-03-206524","volume":"114","author":"KL Rice","year":"2009","unstructured":"Rice, K. L. et al. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood 114, 5499\u20135511 (2009).","journal-title":"Blood"},{"key":"107_CR21","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal, R. & Shaffer, E. A. Gallbladder cancer: epidemiology and outcome. Clin. Epidemiol. 6, 99\u2013109 (2014).","journal-title":"Clin. Epidemiol."},{"key":"107_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/hupa.2001.26474","volume":"32","author":"X Li","year":"2001","unstructured":"Li, X., Hui, A. M., Shi, Y. Z., Takayama, T. & Makuuchi, M. Reducedp21(WAF1\/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum. Pathol. 32, 771\u2013777 (2001).","journal-title":"Hum. Pathol."},{"key":"107_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1245\/s10434-008-0182-x","volume":"16","author":"WB Kim","year":"2009","unstructured":"Kim, W. B. et al. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer. Ann. Surg. Oncol. 16, 23\u201334 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"107_CR24","first-page":"683","volume":"28","author":"FM Alsheyab","year":"2007","unstructured":"Alsheyab, F. M., Ziadeh, M. T. & Bani-Hani, K. E. Expression of p21 and p27 in gallbladder cancer. Saudi. Med. J. 28, 683\u2013687 (2007).","journal-title":"Saudi. Med. J."},{"key":"107_CR25","doi-asserted-by":"crossref","first-page":"47957","DOI":"10.18632\/oncotarget.18204","volume":"8","author":"Q Cai","year":"2017","unstructured":"Cai, Q. et al. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Oncotarget 8, 47957\u201347968 (2017).","journal-title":"Oncotarget"},{"key":"107_CR26","doi-asserted-by":"publisher","first-page":"32507","DOI":"10.1074\/jbc.M212517200","volume":"278","author":"K Lohr","year":"2003","unstructured":"Lohr, K., Moritz, C., Contente, A. & Dobbelstein, M. p21\/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278, 32507\u201332516 (2003).","journal-title":"J. Biol. Chem."},{"key":"107_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97\u2013110 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"107_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1615\/CritRevOncog.2014011802","volume":"19","author":"L Ombrato","year":"2014","unstructured":"Ombrato, L. & Malanchi, I. The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit. Rev. Oncog. 19, 349\u2013361 (2014).","journal-title":"Crit. Rev. Oncog."},{"key":"107_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan, X. Cancer metastases: challenges and opportunities. Acta Pharmaceutica Sinica B 5, 402\u2013418 (2015).","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"107_CR30","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.biocel.2007.07.011","volume":"39","author":"M Guarino","year":"2007","unstructured":"Guarino, M. Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell. Biol. 39, 2153\u20132160 (2007).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"107_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 7, 131\u2013142 (2006).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"107_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","volume":"17","author":"MA Huber","year":"2005","unstructured":"Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell. Biol. 17, 548\u2013558 (2005).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"107_CR33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","volume":"69","author":"MJ de Veer","year":"2001","unstructured":"de Veer, M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69, 912\u2013920 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"107_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"GR Stark","year":"2012","unstructured":"Stark, G. R. & Darnell, J. E. Jr. The JAK-STAT pathway at twenty. Immunity 36, 503\u2013514 (2012).","journal-title":"Immunity"},{"key":"107_CR35","first-page":"911","volume":"86","author":"C Gongora","year":"1999","unstructured":"Gongora, C. & Mechti, N. [Interferon signaling pathways]. Bull. Cancer 86, 911\u2013919 (1999).","journal-title":"Bull. Cancer"},{"key":"107_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","volume":"41","author":"H Cheon","year":"2014","unstructured":"Cheon, H., Borden, E. C. & Stark, G. R. Interferons and their stimulated genes in the tumor microenvironment. Semin. Oncol. 41, 156\u2013173 (2014).","journal-title":"Semin. Oncol."},{"key":"107_CR37","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1541-7786.MCR-14-0450","volume":"12","author":"EN Fish","year":"2014","unstructured":"Fish, E. N. & Platanias, L. C. Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes. Mol. Cancer Res. 12, 1691\u20131703 (2014).","journal-title":"Mol. Cancer Res."},{"key":"107_CR38","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1074\/jbc.M110.207068","volume":"286","author":"M Stawowczyk","year":"2011","unstructured":"Stawowczyk, M., Van Scoy, S., Kumar, K. P. & Reich, N. C. The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286, 7257\u20137266 (2011).","journal-title":"J. Biol. Chem."},{"key":"107_CR39","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/onc.2016.418","volume":"36","author":"H Jia","year":"2017","unstructured":"Jia, H. et al. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1\/STAT1\/IFIT2 network. Oncogene 36, 2655\u20132666 (2017).","journal-title":"Oncogene"},{"key":"107_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2016.08.024","volume":"382","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Cancer Lett. 382, 137\u2013146 (2016).","journal-title":"Cancer Lett."},{"key":"107_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-633","volume":"14","author":"X Feng","year":"2014","unstructured":"Feng, X. et al. MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. BMC. Cancer 14, 633 (2014).","journal-title":"BMC. Cancer"},{"key":"107_CR42","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1038\/onc.2012.384","volume":"32","author":"KC Lai","year":"2013","unstructured":"Lai, K. C., Liu, C. J., Chang, K. W. & Lee, T. C. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells. Oncogene 32, 3686\u20133697 (2013).","journal-title":"Oncogene"},{"key":"107_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider, W. M., Chevillotte, M. D. & Rice, C. M. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513\u2013545 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"107_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fimmu.2013.00267","volume":"4","author":"CM Blouin","year":"2013","unstructured":"Blouin, C. M. & Lamaze, C. Interferon gamma receptor: the beginning of the journey. Front. Immunol. 4, 267 (2013).","journal-title":"Front. Immunol."},{"key":"107_CR45","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1074\/jbc.M112.341198","volume":"287","author":"C Yuan","year":"2012","unstructured":"Yuan, C., Qi, J., Zhao, X. & Gao, C. Smurf1 protein negatively regulates interferon-gamma signaling through promoting STAT1 protein ubiquitination and degradation. J. Biol. Chem. 287, 17006\u201317015 (2012).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0107-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0107-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0107-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:32:31Z","timestamp":1671535951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0107-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0107-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"23 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"71"}}